AstraZeneca will invest $50 billion in the United States by 2030, following similar announcements by other big pharma companies.   The company says the investment will create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America and worldwide.  The […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!